Who should Attend CVCT Middle East 2017?
• Stakeholders to evaluate current and future clinical trial designs in cardiovascular medicine therapeutics (both pharma and devices)
• Actively involving major principal investigators
• Trialists
• Industry
• R& D experts
• Regulators (FDA, EMA, PMDA)
• Institutions (NHLBI, EU, H2020,Inserm)
• Journal editors (NEJM, The Lancet, Circulation, JACC, EHJ)
• Different Societies (ACC, ESC, HFSA,ASN, EACPT, ISCP)
• Statisticians CROs
• Payers
• Practitioners
• Patients
Why Attend CVCT Middle East ?
• It is one of the most unique conferences, a combination of investigators, young researchers and regulators in a very interactive setting.
• You will have the opportunity to not only hear interesting talks and interact with senior trialists, but also to have the chance to interact with other young investigators from around the world.
• The meeting allow you to easily interact with many leaders of the field.
• It is highly recommended if you wish to develop your skills in clinical trial design and update your knowledge about key hot topics in clinical research.”
